Testavan 23 mg, transdermales Gel

7680668160013 CH-66816 Gel
Testavan 23 mg, transdermales Gel
Testavan 23 mg, transdermales Gel
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
85,5
Selling units
85
Measure
g
Galenic form
Gel
Galenic group
Salben

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/09/2026
Patient information leaflet
Français
08/09/2026
Patient information leaflet
Italien
08/09/2026
Summary of Product Characteristics
Allemand
30/06/2026
Summary of Product Characteristics
Français
30/06/2026
Summary of Product Characteristics
Italien
30/06/2026

Detailed composition

Substance Quantity Type Category
testosteronum
23.0 MG Substance Wirkstoff (Principe actif)
ethanolum 96 per centum
540.0 MG Substance HBESI
propylenglycolum
230.0 MG Substance HBESI
diethylenglycoli monoethylicum aetherum
- Substance HNIDK
carbomerum 980
- Substance HNIDK
trolaminum
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
aqua purificata
- Substance HNIDK

Authorization holder

EffRx Pharmaceuticals SA

8807 Freienbach

Authorization information

Swissmedic authorization number
66816
Drug name
Testavan, transdermales Gel
Galenic form
TRDG
ATC Code
G03BA03
Authorization status
Z
Dispensing category
B
First authorization
12/06/2019
Authorization expiration date
31/12/9999
IT Number
07.08.4.
Domain
Human medicine
Field of application
Männlicher Hypogonadismus

Package details

Description (FR)
TESTAVAN gel 23 mg fl dos 85.5 g
Description (DE)
TESTAVAN Gel 23 mg Dosierfl 85.5 g
Market launch
12/06/2019
Narcotic (BTM)
No

Available generics (3)

Testone, Injektionslösung
GTIN: 7680705700011
CHF 70.35
View
Testosteron-Mepha, Injektionslösung
GTIN: 7680689890012
CHF 77.20
View
Testosteron Spirig HC, Injektionslösung
GTIN: 7680689760025
CHF 77.20
View
Buy us a coffee Explore the data